Abdulrahman Alardan, H. Alkhudairi, Ghanim Almotiri, Saad Shamsy
{"title":"Role of methylphenidate in cancer-related fatigue: A Systemic Review","authors":"Abdulrahman Alardan, H. Alkhudairi, Ghanim Almotiri, Saad Shamsy","doi":"10.5455/jcmr.2023.14.03.35","DOIUrl":"https://doi.org/10.5455/jcmr.2023.14.03.35","url":null,"abstract":"Introduction: Cancer-related fatigue (CRF) is a substantial medical issue that affects patients at all phases of their therapy and escalates with advanced cancer. To gather indications for the use of methylphenidate is objective of the study for the treatment of CRF, as well as to analyse the efficiency and safety of methylphenidate for the treatment of CRF so that we can tailor methylphenidate treatment to response patient only. Methods: To conduct the review of RCTs Systematic Reviews (PRISMA) statement was ideally chosen for Reporting Items. From inception through the first week of October 2021, A systematic search of the electronic databases PubMed, Embase, PSYCHInfo, and the Cochrane Library was done without any language restrictions. This helped to find all RCTs about the use of methylphenidate in patients with CRF. Search terms used were: methylphenidate, dexmethylphenidate, Ritalin, cancer, tumor, carcinoma, neoplasm, fatigue, asthenia, tiredness, CRF, and RCT. We also looked over a few journals' references to find more theoretically related papers. Results: A total of 267 citations were screened; among them, after a preliminary review 231 were excluded. 36 full-text articles assessed for eligibility; among them, 10 articles were met the inclusion criteria where all the selected articles were of good quality. Among 10 studies, 5 were identified in mixed tumor, 2 in prostate cancer, 1 in GI cancer, 1 in advanced cancer and 1 in Gynaecologic cancer. The characteristics of the studies changed broadly in terms of the treatment term and the population studied. Conclusion: To summarize up this study, cancer-related weakness could be critical clinical issue for cancer patients. Our findings suggest that methylphenidate may be useful in the treatment of CRF, but the evidence is inconclusive and has to be confirmed in a bigger study. All of the investigations, however, had tiny sample sizes. This counsel must be respected as provisional and temporary within the absence of considerable information from a single, expansive, well conducted randomized controlled trial. To support and propose new research topics and interventions, more study into biological factors affecting weariness is required.","PeriodicalId":41505,"journal":{"name":"Journal of Complementary Medicine Research","volume":null,"pages":null},"PeriodicalIF":0.6,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"80719023","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Antimicrobial And Cytotoxic Effect of Selenium Nanoparticles Synthesized Using Clove and Cumin Formulation","authors":"Mufeetha M, R. S, T. Lakshmi","doi":"10.5455/jcmr.2023.14.03.17","DOIUrl":"https://doi.org/10.5455/jcmr.2023.14.03.17","url":null,"abstract":"Aim: The purpose of this study is to use clove and cumin extract to produce the selenium nanoparticles via green approach. Selenium nanoparticles synthesized using clove and cumin formulation nanotechnology explores a lot of interesting approaches in the field of biomedicine. Researchers have recently developed interest in biomolecule-mediated nanoparticle production because of its eco-friendly and non-toxic properties. Clova and cumin have long been used in traditional medicine to treat various illnesses. Materials And Method: Collection of clove and cumin extract then 1 g of clove and cumin, powder was dissolved in distilled water and boiled for 5–10 min at 60–70C. The solutions were then filtered using Whatman No. 1 filter paper. The filtered extract was collected, synthesis of seleniu","PeriodicalId":41505,"journal":{"name":"Journal of Complementary Medicine Research","volume":null,"pages":null},"PeriodicalIF":0.6,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75916723","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Economics And Pricing of Certain Segments of The Pharmaceutical Market","authors":"No author No author","doi":"10.5455/jcmr.2023.14.03.21","DOIUrl":"https://doi.org/10.5455/jcmr.2023.14.03.21","url":null,"abstract":"Pharmaceutical innovations over the past half century have made it possible to effectively treat and prevent a wide range of diseases. These achievements were so important for modern healthcare that equal access to them is considered one of the basic human rights. This article examines the economics and pricing in certain segments of the pharmaceutical market. The authors analyze various aspects affecting drug prices and price formation mechanisms in various segments of the pharmaceutical industry. The article considers the role of pharmaceutical companies, government regulators and consumers in determining the prices of medicines. The authors investigate the influence of factors such as research and development costs, production costs, patent protection, supply and demand, as well as political and regulatory measures on the formation of prices for pharmaceuticals. It is noted that although the demand for medicines is one of the driving forces of pharmaceutical spending, price increase is the main problem for health system managers, as drug prices increasingly seem unfair. The paper also analyzes various pricing strategies used by pharmaceutical companies, including differentiated pricing, cost pricing and pricing based on the value for a patient. The authors explore the advantages and limitations of each strategy and offer recommendations on the optimal choice of pricing strategy in different segments of the pharmaceutical market. The article ends with the main conclusions and offers recommendations for pharmaceutical companies and government regulators regarding effective pricing in certain segments of the pharmaceutical market, taking into account economic, political and social factors. The study has an important meaning for understanding the complexities and challenges associated with pricing in the pharmaceutical industry and helps to determine optimal pricing strategies for various market segments.","PeriodicalId":41505,"journal":{"name":"Journal of Complementary Medicine Research","volume":null,"pages":null},"PeriodicalIF":0.6,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77325076","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Comparison Of Histomorphology, Angiogenesis and Proliferation in Kappa and Lambda Restricted Plasma Cell Myelomas with Its \u0000Effect on Prognosis","authors":"S. Priyadarshini, D. Basu, R. Kar, T. Dutta","doi":"10.5455/jcmr.2023.14.03.13","DOIUrl":"https://doi.org/10.5455/jcmr.2023.14.03.13","url":null,"abstract":"Aims Of the Study: To study the type of light chain restriction and correlate it with the morphological parameters, proliferation index, angiogenesis and clinical parameters. Materials And Methods: The study includes 46 cases of myeloma diagnosed over the period of five years. The histomorphological features like plasma cell morphology, percentage of plasma cells and pattern of infiltration were studied. Immunohistochemistry for kappa and lambda light chains was done. Angiogenesis was assessed by calculating the microvessel density (MVD) using anti CD34 immunohistochemistry. Proliferation was assessed immunohistochemically using Ki67 by comparing with anti CD38 which was used to highlight the plasma cells. Results: The cases with kappa light chain restriction had significantly less of poorly differentiated morphology (7.4% vs 36.8%; p=0.02) and diffuse pattern of infiltration (22% vs 63%; p=0.01) compared to lambda. The kappa group also had lower MVD (9.9 vs 16.5; p=0.02) and proliferation index (4.7 vs 94; p=0.04) compared to the lambda. Conclusion: Therefore, the type of light chain restriction is also a prognostic factor in plasma cell myeloma.","PeriodicalId":41505,"journal":{"name":"Journal of Complementary Medicine Research","volume":null,"pages":null},"PeriodicalIF":0.6,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"79205333","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}